Jodi Pantuck, BBA
Jodi is the Chief of Staff and Operations at Athos Therapeutics Inc. She worked as a CPA for many years in New York before relocating to Los Angeles. She has experience with all aspects of financial accounting and ensures that the books and records of Athos are accurate and are recorded in accordance with GAAP […]
Keith B. Hoffman, PhD
Dr. Hoffman is the Chief Business Officer of Athos Therapeutics Inc. Prior to Athos, he was the Senior Vice President of Business Development and Technology Transfer at the Lundquist Institute for Biomedical Innovation at the Harbor-UCLA Medical Center, a research institute with over 400 scientists and 600 research projects. Keith oversaw all commercialization, licensing, startup […]
Allan J. Pantuck, MD MS
Dr. Allan Pantuck is the Chairman, co-Founder, and Chief Medical Officer of Athos Therapeutics Inc. He was a co-founder of Kite Pharma, a biotech company that successfully developed and obtained FDA approval for an innovative cancer immunotherapy and was acquired from Gilead Sciences in 2017. He is currently a Professor of Urology at UCLA David […]
Dimitrios Iliopoulos, PhD MBA
Dr. Dimitrios Iliopoulos is the President, CEO and a co-Founder of Athos Therapeutics Inc. He started his academic career at Harvard Medical School where he was an Assistant Professor of Microbiology & Immunology. More recently, he was a tenured Associate Professor of Medicine at UCLA School of Medicine and Founder & Director of the UCLA […]
Iordanis Karagiannidis, PhD
Dr. Karagiannidis is the Chief Scientific Officer in Athos Therapeutics Inc. Currently, he organizes and oversees all the in vitro and in vivo preclinical drug discovery & development studies. He has an extensive experience studying the pathobiology of Inflammatory Bowel Diseases and working with different IBD mouse models. He received his Ph.D from Boston University […]
Dimitra Chalkia, PhD
Dr. Dimitra Chalkia is the Vice President of Computational Modeling at Athos Therapeutics Inc. She is overseeing all the bioinformatic and machine learning efforts related to Athos drug development programs and with the identification of the central regulators (hubs) involved in the pathogenesis of different autoimmune diseases, including ulcerative colitis and Crohn’s Disease. Prior joining […]
Phithi Nguyen, BSc.
Phithi is the Vice President of Analytical Chemistry in Athos Therapeutics Inc. She oversees all the bioanalytical assays, including designing experiments to understand the absorption, distribution, metabolism, excretion and transport (ADME) properties of drug candidates to support research and IND filing. She brings more than 10 years of pharmaceutical experience in bioanalytical DMPK support for […]
David G. Ho, PhD
Dr. Ho is the Vice President of Medicinal Chemistry in Athos Therapeutics Inc. He is leading all medicinal and synthetic chemistry efforts and is developing an innovative small molecule chemistry platform based on computational structural and synthetic chemistry methodologies. He previously worked at NantBioscience as a Senior Scientist and led the KRAS inhibitor and Antibody-Drug […]